Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative subpterygeal injection of bevacizumab vs mitomycin C for pterygium surgery
IRCT2016042227525N1Phase 2Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- May 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab and mitomycin c in pterygium (2 arms), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
bevacizumabmitomycin c
03
Conditions
pterygium
Beyond the preview
Go deeper on IRCT2016042227525N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016042227525N1.